Diary

  • Wed
    02
    Sep
    2020

    Royal Marsden Hospital

    Description: In this course I describe the faulty genes, pathways and proteins that drive small cell and non-small cell lung cancer. I also explain the scientific rationale behind targeted treatments in use and in development for these diseases, such as EGFR inhibitors, ALK and ROS1 inhibitors, B-Raf inhibitors, angiogenesis inhibitors and immunotherapy with checkpoint inhibitors.
    Level: Intermediate/Advanced
    Audience: Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
    Cost: £150
    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
    View an outline of the programme

  • Fri
    04
    Dec
    2020

    9;30am - 4pmRoyal Marsden Hospital, London

    Description: This is a one-day course in which I describe the science behind a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. Treatments described include: kinase inhibitors, monoclonal antibodies, PARP inhibitors,  CDK inhibitors, immunotherapy with checkpoint inhibitors.
    Level: Intermediate/Advanced
    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
    Cost:
    £150
    To book, contact: conferenceteam@rmh.nhs.uk
    View the day's programme

  • Wed
    09
    Dec
    2020

    9:30am - 4pmRoyal Marsden Hospital, London

    Description: A one-day course on the biology and genetics of malignant melanoma and the science behind the latest treatment approaches. Both BRAF/MEK inhibitors and checkpoint inhibitors will be explained and the latest trial data presented. The day will also include an overview of novel treatments such as antigen and DNA vaccines and other agents in early phase trials.
    Level: Intermediate/Advanced
    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
    Cost:
    £150
    To book, contact: conferenceteam@rmh.nhs.uk
    View the day's programme

  • Mon
    11
    Jan
    2021

    Half dayRoyal Marsden Hospital, London

    Description: A half-day course repeated morning and afternoon describing the theory behind the new immunotherapy treatments for cancer such as checkpoint inhibitors (ipilimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab), adoptive cell therapy (CAR T cell therapy, infiltrating T cells), and vaccine-based treatments (peptide and DNA vaccines, oncolytic viruses, dendritic cell vaccines).
    Level: Intermediate
    Cost: £100
    Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.
    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
    View an outline of the programme

  • Tue
    02
    Feb
    2021

    Royal Marsden Hospital, London

    Description: In this study day I describe the unique cellular and genetic features of haematological cancers and covers a diverse range of targeted treatments for leukaemias, lymphomas and multiple myeloma. Treatments explained include a wide range of monoclonal antibodies, B cell receptor signalling blockers and JAK2, Bcl-2, FLT3 and CDK inhibitors. I also explore the potential of immunotherapy with checkpoint inhibitors and CAR T cells.
    Level: Intermediate/Advanced
    Audience:Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
    Cost: £150
    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
    View an outline of the programme